News and Updates

What’s Happening? The U.S. Food and Drug Administration (FDA) approved Abbott’s Libre Duo 10 Day, the world’s first two-in-one sensor that monitors both glucose and ketones. People with diabetes ages two and up will soon be able to access this technology in the U.S. This follows from its recent approval in Europe earlier this year. […]

Spotlight on Jessie Stover Jessie Stover is the Development Manager at Breakthrough T1D’s Indiana Chapter. Stover was born and raised in Evansville, Indiana, and she now lives in Indianapolis with her two cats, Milo and Zuko. She enjoys reading, crafting, concerts, and “baking gluten-free desserts so good that no one can tell they’re gluten-free.” Here, […]

Time in range is a metric measured by continuous glucose monitors. Learn about why it matters and future applications.

ADA’s 86th Scientific Sessions This event is one of the largest diabetes conferences in the world, bringing together over 11,000 attendees to share and learn about cutting-edge research and advancements toward cures. Each year, Breakthrough T1D-funded researchers highlight their work, demonstrating the progress we’re making toward achieving our mission. Leading experts will present over 100 […]

Tandem’s Control-IQ+ is the first-ever automated insulin delivery system cleared in the U.S. for pregnancy with type 1 diabetes.

Breakthrough T1D created a guide for sensor issues, from what to do if symptoms and CGM reading do not match to how to get a replacement.

Breakthrough T1D sat down with Mason Miller to learn more about his journey with type 1 diabetes and the impact it has on him as an athlete.

Skin reactions from adhesives on insulin pumps and CGMs are common. Learn why they occur and how to reduce irritation.

What is the pipeline? Every new medical device, therapy, treatment, and drug—including those for type 1 diabetes (T1D)—goes through the drug development pipeline. Getting a new therapy or device from the earliest stages of research eventually into the hands of people with T1D is a complicated process. Science takes time (from years to decades!), money […]

Analysis compiled by Avalere Health and supported by Breakthrough T1D (formerly JDRF) finds that research funded by the Special Diabetes Program (SDP) has yielded more than $50 billion in federal healthcare savings.  Created by Congress in 1997 and administered by the National Institutes of Health (NIH), the SDP provides federal funding to support research to prevent, treat, and […]